Radnor Capital Management LLC Has $1.14 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Radnor Capital Management LLC cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 1.1% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,130 shares of the company’s stock after selling 167 shares during the period. Radnor Capital Management LLC’s holdings in Henry Schein were worth $1,143,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. HighTower Advisors LLC increased its stake in Henry Schein by 54.1% during the 3rd quarter. HighTower Advisors LLC now owns 13,370 shares of the company’s stock worth $992,000 after acquiring an additional 4,695 shares during the period. Rafferty Asset Management LLC increased its position in shares of Henry Schein by 7.1% in the third quarter. Rafferty Asset Management LLC now owns 13,627 shares of the company’s stock worth $1,012,000 after purchasing an additional 904 shares during the period. FMR LLC lifted its position in Henry Schein by 9.6% during the third quarter. FMR LLC now owns 934,132 shares of the company’s stock worth $69,359,000 after purchasing an additional 81,943 shares during the period. V Square Quantitative Management LLC acquired a new stake in Henry Schein during the third quarter worth about $188,000. Finally, Acadian Asset Management LLC grew its stake in Henry Schein by 196.7% during the third quarter. Acadian Asset Management LLC now owns 18,119 shares of the company’s stock worth $1,341,000 after buying an additional 12,012 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HSIC has been the topic of several analyst reports. JPMorgan Chase & Co. increased their price target on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. SVB Leerink assumed coverage on Henry Schein in a report on Monday, February 26th. They issued a “market perform” rating and a $78.00 target price on the stock. Jefferies Financial Group upped their price objective on Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. Leerink Partnrs reiterated a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, Piper Sandler reissued an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a report on Friday. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Henry Schein presently has a consensus rating of “Hold” and an average price target of $81.73.

Henry Schein Trading Up 1.1 %

HSIC opened at $67.26 on Monday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The company’s 50 day moving average price is $70.44 and its two-hundred day moving average price is $73.13. The firm has a market capitalization of $8.61 billion, a price-to-earnings ratio of 22.72, a PEG ratio of 1.64 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. Henry Schein’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.21 earnings per share. As a group, research analysts predict that Henry Schein, Inc. will post 5.17 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.